PharmaCyte Biotech PMCB
NASDAQ PMCB
$0.40 -0.01 (-1.63%)
As of: Oct 1, 2026 · 3:59 PM EDT

PharmaCyte Biotech (PMCB) Return on Equity [ROE] (2013 - 2026)

Updated

PharmaCyte Biotech's Return on Equity [ROE] came in at -20.82% for fiscal Q1 2027 (quarter ended Jul 31, 2026), down 14.81 percentage points from -6.01% a year earlier and down 3.68 percentage points from the prior quarter.

Analysis

PharmaCyte Biotech (PMCB) Return on Equity [ROE] (2013 - 2026) Analysis & Trends

For FY2026 (ended Apr 30, 2026), PharmaCyte Biotech's Return on Equity [ROE] was -14.37%, down 6.92 percentage points from FY2025.

  • Return on Equity [ROE] carries a five-year change of +47.25 percentage points (FY2021 to FY2026).
  • Going back by fiscal year, Return on Equity [ROE] was -7.45% in FY2025 (+2.76 pp), -10.21% in FY2024 (-4.65 pp), -5.56% in FY2023 (+3.21 pp) and -8.77% in FY2022 (+52.86 pp).
  • The fiscal Q1 2027 figure represents the lowest quarterly Return on Equity [ROE] since fiscal Q1 2022.
  • Year-over-year, Return on Equity [ROE] has declined for three consecutive quarters, with an average year-over-year change of -1.64 percentage points over the last eight quarters.
  • The fastest year-over-year change in Return on Equity [ROE] over five years came in fiscal Q1 2023 (a gain of 55.41 percentage points), and the weakest in fiscal Q1 2027 (a drop of 14.81 percentage points).
  • Business Quant data shows PMCB's Return on Equity [ROE] at -17.14% (Q4 2026), -12.27% (Q3 2026) and -8.42% (Q2 2026) in the three fiscal quarters before Q1 2027.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROE (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 25.32%
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 7.21%
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 84.40%
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 21.39%
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 83.75%
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -18.38%
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 4.97%
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 22.24%
10 PharmaCyte Biotech 4.40 Mn 4.40 Mn - -20.82%
Historic Data

Historic Data

Download Data
DateValue
Jul 31, 2026 -20.82%
Apr 30, 2026 -17.14%
Jan 31, 2026 -12.27%
Oct 31, 2025 -8.42%
Jul 31, 2025 -6.01%
Apr 30, 2025 -6.43%
Jan 31, 2025 -10.92%
Oct 31, 2024 -10.64%
Jul 31, 2024 -12.32%
Apr 30, 2024 -17.35%
Jan 31, 2024 -8.46%
Oct 31, 2023 -7.40%
Jul 31, 2023 -7.47%
Apr 30, 2023 -6.03%
Jan 31, 2023 -7.28%
Oct 31, 2022 -6.76%
Jul 31, 2022 -5.39%
Apr 30, 2022 -4.67%
Jan 31, 2022 -4.20%
Oct 31, 2021 -7.76%
API Access

PharmaCyte Biotech Return on Equity [ROE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=PMCB&period=max&api_key=YOUR_API_KEY